Press Release InView Vision
The leader in vision correction.

Media Contacts:
Karen Keiser-Jenkins
InView
678-222-5142
karenjenkins@inviewvision.com |
Claudia D'Avanzo/Jen Dunaway
For InView
404-898-0423 davanzo@healthcomminc.com |
Epi-LASIK®, Next Generation
of Laser Vision Correction Surgery, Now Available in Atlanta at
InView.
ATLANTA, Nov. 9, 2005 - Epi-LASIK® is a revolutionary procedure that allows new treatment options for
patients who were previously not good candidates for LASIK. Epi-LASIK
is now available at InView, Atlanta's research-based leader in vision
correction surgery. The procedure was recently featured as a part
of a special on advancements in vision correction on NBC-TV's "Today"
show.
This next-generation technology offers an alternative to the corneal
flap traditionally used in LASIK surgery. It provides patients with
a bladeless surgical approach designed to avoid flap-related complications,
potentially minimize visual distortions, and present another treatment
option for patients who want to reduce their dependence on glasses
or contact lenses.
"This new technology, combined with InView's exclusive wavefront
technology, gives our patients the most advanced options for vision
correction," said InView surgeon Jonathan Carr, M.D. Since 1993,
InView surgeons Jonathan Carr, M.D., Keith Thompson, M.D. and George
Waring, M.D. have brought vision surgery patients many "firsts."
"The Epi-LASIK complements our existing treatment options to offer
our patients the latest and most comprehensive treatments in surgical
vision correction," Carr added.
The Newest Advances in Vision Surgery
Epi-LASIK, which features the Epikeratome System, is U.S. Food and
Drug Administration (FDA) 510(k)-approved and a European CE certified
instrument. With this new system, surgeons can reduce the chance
of post-surgical risks and complications associated with LASIK,
such as dry eye. This technology also offers new surgical vision
correction options for patients who have been non-candidates for
LASIK due to dry eyes, thin corneas or high myopia.
InView surgeons have led the way in the evolution of laser vision
correction surgery since the early '80s. In 1981, Waring was selected
by the U.S. Federal Government's National Eye Institute to direct
the Prospective Evaluation of Radial Keratotomy (PERK) study, the
largest and most comprehensive clinical investigation of radial
keratotomy, one of the first vision correction surgery treatments
available.
Photorefractive Keratotomy (PRK) surgery was the first generation
of laser vision correction surgery, in which the laser correction
was applied directly to the eye's surface by using an excimer laser.
These procedures were painful and recovery could be prolonged. In
the early '90s, Waring performed one of the first LASIK procedures
in the U.S. using the excimer laser. He was then awarded the first
physician-sponsored FDA clinical trial for the LASIK procedure.
LASIK reduced the pain and recovery time of patients by creating
a flap, applying the laser treatment and replacing the flap, which
acted like a bandage to eliminate pain and reduce recovery time.
Now, InView is the first to offer this latest development in surgical
vision correction available in the Atlanta area.
"In the past, patients who had very thin corneas or high levels
of nearsightedness were not ideal candidates for LASIK surgery,"
Waring explained. "InView has been at the forefront of introducing
new technologies that allow surgeons to give more patients the opportunity
to live life free of contacts and glasses. Epi-LASIK is an advancement
in laser vision correction for nearsighted patients, or those with
thin corneas."
How It Works
In traditional LASIK surgery, a flap is created with the use of
a blade or laser. The Epi-LASIK system utilizes a separator rather
than a blade to create a thin sheet of surface cells and eliminates
the need for alcohol or other chemical agents, which can be toxic
to the cornea. Because of this, complications sometimes associated
with the blade, such as flap complications or aberrations induced
by the flap, can be eliminated. Following the application of the
laser correction to the cornea, the thin sheet is returned to its
original position. Custom or wavefront-guided laser treatments are
best when coupled with the Epi-LASIK surface treatment rather than
the flap-based technology because of the reduced risk of flap induced
aberrations.
About InView
InView is a state-of-the-art vision surgery center founded in 1994.
It is the only center in the country to offer the revolutionary
InterWave® technology, a subjective system of vision measurement
and individualized, patient-interactive treatment in LASIK surgery.
InView has performed more than 40,000 LASIK procedures, and the
Center offers patients the widest range of options for vision correction
surgery and treatment. InView is located at 301 Perimeter Center
North, Suite 600, Atlanta, Ga., 30346. For more information, go
to www.inviewvision.com or call 404-843-3937.
Editor's Note: Photography and video images are
available by calling Karen Keiser-Jenkins at 678-222-5142 or send
email request to karenjenkins@inviewvision.com.
|